Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?

Aberrant activity of tyrosine kinases has been proved to be associated with multiple diseases including fibrotic diseases. Tyrosine kinases inhibitors (TKIs) might be a novel approach to transform the anti-fibrotic treatment. However, both beneficial and adverse effects are observed by researchers w...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Kai, Liu, Tian, Lin, Ting, Zhang, Xing, Cui, Ruixia, Liu, Sinan, Meng, Fandi, Zhang, Jingyao, Tai, Minghui, Wan, Yong, Liu, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341902/
https://www.ncbi.nlm.nih.gov/pubmed/27588502
http://dx.doi.org/10.18632/oncotarget.11767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341902/
https://www.ncbi.nlm.nih.gov/pubmed/27588502
http://dx.doi.org/10.18632/oncotarget.11767

Ejemplares similares